title: Transurethral electrovaporization of the prostate: is it any better than conventional transurethral resection of the prostate?
abstract: OBJECTIVE
  To evaluate transurethral electrovaporization of the prostate (TUVP), compared with transurethral resection of the prostate (TURP), as a treatment for men with symptomatic benign prostatic enlargement (BPE).
  
  
  METHODS
  In all, 235 men with symptomatic BPE in four hospitals in the South-East of England were randomized to TUVP (115) and TURP (120). Patients were assessed using the International Prostate Symptom Score (IPSS), the Short Form-36 (SF-36), EuroQol and sexual function questionnaire, uroflowmetry, ultrasonographic measurement of residual urine volume, pressure-flow urodynamics and transrectal ultrasonography.
  
  
  RESULTS
  There was no statistically significant difference in the objective and subjective outcome after TURP and TUVP. The latter was associated with a lower transfusion rate than TURP but this did not result in an overall reduction in complications. There was no difference in the length of hospital stay. Overall, the two operations produced equivalent results and equivalent complication rates.
  
  
  CONCLUSIONS
  TUVP is an effective treatment for symptomatic BPE, with results equivalent to TURP. TUVP has not led to the expected reduction in early postoperative morbidity or shorter hospital stays.
authors.affiliation: Department of Urology, The Royal London Hospitals NHS Trust, UK. bill@mcallisterfamily.freeserve.co.uk
authors.forename: W J
authors.initials: WJ
authors.lastname: McAllister
authors.forename: O
authors.initials: O
authors.lastname: Karim
authors.forename: R O
authors.initials: RO
authors.lastname: Plail
authors.forename: D R
authors.initials: DR
authors.lastname: Samra
authors.forename: M J
authors.initials: MJ
authors.lastname: Steggall
authors.forename: Q
authors.initials: Q
authors.lastname: Yang
authors.forename: C G
authors.initials: CG
authors.lastname: Fowler
mesh_terms: D000368:Aged; D017115:Catheter Ablation / Q000379:methods*; D007172:Erectile Dysfunction / Q000209:etiology; D005500:Follow-Up Studies; D006801:Humans; D007902:Length of Stay; D008297:Male; D011183:Postoperative Complications / Q000209:etiology; D011468:Prostatectomy / Q000379:methods*; D011470:Prostatic Hyperplasia / Q000601:surgery*; D020728:Transurethral Resection of Prostate / Q000379:methods; D016896:Treatment Outcome